ABSTRACT
We report an observation of one of the rarest coronary arteries anomaly, type IV dual left arterior descending artery in 43-year-old man. The patient arrived with angina pectoris and underwent multispiral computed tomography of coronary arteries, having revealed abnormal anatomy as well as atherosclerotic lesion of coronary arteries. Hemodynamically signification stenoses were successfully eliminated by the way of coronary stending.
Subject(s)
Angina Pectoris , Angioplasty, Balloon, Coronary , Coronary Artery Disease , Coronary Vessel Anomalies , Stents , Adult , Angina Pectoris/diagnosis , Angina Pectoris/etiology , Angina Pectoris/physiopathology , Angina Pectoris/therapy , Coronary Angiography , Coronary Artery Disease/complications , Coronary Artery Disease/diagnosis , Coronary Artery Disease/physiopathology , Coronary Artery Disease/therapy , Coronary Vessel Anomalies/complications , Coronary Vessel Anomalies/diagnosis , Coronary Vessel Anomalies/physiopathology , Coronary Vessels/pathology , Coronary Vessels/physiopathology , Echocardiography , Electrocardiography , Humans , Incidental Findings , Male , Tomography, Spiral Computed , Treatment OutcomeABSTRACT
Fourteen patients aged 34-54 years underwent aortocoronary bypass surgery for early postinfarction angina within 30 days following myocardial infarction. In periods up to 1.5 years after surgery, angina pectoris was not detected in the patients; cases of recurrent myocardial infarction were not registered.
Subject(s)
Angina Pectoris/surgery , Coronary Artery Bypass , Myocardial Infarction/complications , Adult , Angina Pectoris/etiology , Extracorporeal Circulation , Female , Heart Arrest, Induced , Humans , Male , Middle Aged , Myocardial Infarction/prevention & control , Recurrence , Time FactorsABSTRACT
Intravenous jet injections of 50 mg ethacizine (10 mg/min) are effective in 100% of cases of ventricular extrasystoles, and paroxysms of supraventricular and ventricular tachycardia, and in 59.5% of cases of atrial fibrillation paroxysms. A relationship has been demonstrated between the magnitude of therapeutic effect and the duration of atrial fibrillation as well as the type of underlying disease. The use of the drug is not justified in paroxysmal auricular flutter. Ethacizine is effective in 82.4% of patients with acute myocardial infarction, and in 65% of patients with other diseases. A similar effect was obtained with intravenous drip injections at the rate of 1.7 mg/min, while the incidence of side effects was reduced essentially. Therefore, drip injections of ethacizine are preferable for the treatment of heart rhythm disorders, such as extrasystoles, particularly in patients with acute myocardial infarction.
